Skip to main content
Intrasense logo

Intrasense — Investor Relations & Filings

Ticker · ALINS ISIN · FR0011179886 LEI · 969500VF6MOVQXWHAE33 PA Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 310 across all filing types
Latest filing 2017-01-10 Regulatory Filings
Country FR France
Listing PA ALINS

About Intrasense

https://www.intrasense.fr/

Intrasense, a subsidiary of the Guerbet Group, is a medical technology company that develops and markets advanced software solutions for medical imaging. Its flagship product, the Myrian® platform, is a comprehensive visualization tool that assists healthcare professionals in reviewing and analyzing 2D and 3D medical images from modalities such as MRI and CT scanners. The company's solutions are characterized by the native integration of Artificial Intelligence (AI) algorithms to enhance diagnostic accuracy and workflow efficiency. Intrasense also offers specialized solutions, including Liflow® for oncology imaging and the DUOnco™ suite of AI tools for lesion detection. The technology aims to facilitate and secure clinical diagnosis, decision-making, and therapeutic monitoring for radiologists and other clinicians.

Recent filings

Filing Released Lang Actions
Nouveaux succès commerciaux aux États-Unis et au Moyen-Orient pour Intrasense
Regulatory Filings Classification · 95% confidence The document is a press release ('Communiqué de presse') dated January 10, 2017, announcing new commercial successes and firm orders totaling $405,000 USD secured in December, primarily during the RSNA conference. This type of announcement, detailing recent business achievements, contract signings, and sales figures, is characteristic of an Earnings Release (ER) or a general business update. Since it focuses on recent financial/commercial performance highlights rather than a full periodic report (like 10-K or IR), 'ER' (Earnings Release) is the most appropriate classification. It is not a transcript (CT), a formal annual report (10-K), or a specific regulatory filing like DIRS or DIV. Given its nature as an immediate announcement of results/successes, ER fits best.
2017-01-10 French
Intrasense présente la nouvelle version de Myrian® au salon mondial de la radiologie à Chicago
Regulatory Filings Classification · 95% confidence The document is a 'Communiqué de presse' (Press Release) dated November 23, 2016, announcing that the company Intrasense will present the new version of its product Myrian® at the RSNA (Radiological Society of North America) event in Chicago. It details product innovations, strategic positioning (OEM), and partnerships. This type of announcement, which communicates news, product updates, or event participation via a press release format, does not fit neatly into the specific financial filing categories like 10-K, ER, or IR. Since it is a general corporate announcement that doesn't fit the other specific categories (like M&A, Director Dealing, Dividend, etc.), the most appropriate fallback category is Regulatory Filings (RNS), as press releases often serve as general regulatory disclosures or market communications.
2016-11-23 French
Intrasense : rapport financier semestriel 2016
Interim / Quarterly Report Classification · 100% confidence The document is a 'Rapport Financier du Conseil d'Administration' (Board of Directors' Financial Report) for the period ending June 30, 2016. It contains detailed financial analysis, management commentary on business activities, and financial statements (Bilan, Compte de résultat). Since it covers a period shorter than a full fiscal year (a half-year report) and includes substantive financial data and analysis, it is classified as an Interim/Quarterly Report. H2 2016
2016-11-02 French
Intrasense sélectionné pour participer à Medstartup 2016 et concourir au prestigieux Prix Galien
Regulatory Filings Classification · 95% confidence The document is titled "Communiqué de presse" (Press Release) and announces that the company Intrasense has been selected to participate in the MedStartup 2016 competition and compete for the Galien Prize. This is a general announcement regarding company news, visibility, and potential partnerships, rather than a formal regulatory filing like a 10-K, an earnings release (ER), or a specific financial report (IR, AR). Since it is a general corporate announcement that doesn't fit the highly specific categories (like DIRS, DIV, CAP, etc.), the most appropriate fallback category is Regulatory Filings (RNS), which serves as a general announcement category for non-standard regulatory communications.
2016-10-24 French
Intrasense annonce l’émission d’une deuxième tranche d’OCABSA pour un montant global de 1 000 000 €.
Capital/Financing Update Classification · 99% confidence The document is a press release announcing the issuance of a second tranche of convertible bonds with warrants attached (OCABSA) for a total amount of 1,000,000 €. This action directly relates to the company's financing activities and capital structure changes. Based on the definitions, this aligns perfectly with the 'Capital/Financing Update' category (CAP). The document is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it details a specific financing event.
2016-10-13 French
Fin du contrat de liquidité avec la société GILBERT DUPONT et mise en œuvre d’un contrat de liquidité avec la société TSAF
Capital/Financing Update Classification · 99% confidence The document announces a change in the company's liquidity contract: terminating one with GILBERT DUPONT and implementing a new one with TSAF. This action relates to managing the company's share structure or market stability, often involving the company buying back or issuing shares, or managing market making/liquidity provision. Since the core action is the implementation/termination of a liquidity contract, which directly impacts the availability or trading of shares, it aligns best with 'Transaction in Own Shares' (POS) or potentially 'Capital/Financing Update' (CAP). Given the context of liquidity contracts (often related to share buybacks or stabilization), POS is the most specific fit. It is not a standard regulatory report (10-K, IR, ER) nor a general announcement (RNS). The document is short and details a specific corporate action regarding share liquidity management.
2016-07-06 French

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.